These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

707 related articles for article (PubMed ID: 30791416)

  • 1. Autophagy Activator Drugs: A New Opportunity in Neuroprotection from Misfolded Protein Toxicity.
    Thellung S; Corsaro A; Nizzari M; Barbieri F; Florio T
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30791416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological activation of autophagy favors the clearing of intracellular aggregates of misfolded prion protein peptide to prevent neuronal death.
    Thellung S; Scoti B; Corsaro A; Villa V; Nizzari M; Gagliani MC; Porcile C; Russo C; Pagano A; Tacchetti C; Cortese K; Florio T
    Cell Death Dis; 2018 Feb; 9(2):166. PubMed ID: 29416016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynasore Suppresses mTORC1 Activity and Induces Autophagy to Regulate the Clearance of Protein Aggregates in Neurodegenerative Diseases.
    Chen Y; Xu S; Wang N; Ma Q; Peng P; Yu Y; Zhang L; Ying Z; Wang H
    Neurotox Res; 2019 Jul; 36(1):108-116. PubMed ID: 30924108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
    Ciechanover A; Kwon YT
    Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic strategies for targeting neurodegenerative protein misfolding disorders.
    Scannevin RH
    Curr Opin Chem Biol; 2018 Jun; 44():66-74. PubMed ID: 29902695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The spread of prion-like proteins by lysosomes and tunneling nanotubes: Implications for neurodegenerative diseases.
    Victoria GS; Zurzolo C
    J Cell Biol; 2017 Sep; 216(9):2633-2644. PubMed ID: 28724527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkin Protects Against Misfolded SOD1 Toxicity by Promoting Its Aggresome Formation and Autophagic Clearance.
    Yung C; Sha D; Li L; Chin LS
    Mol Neurobiol; 2016 Nov; 53(9):6270-6287. PubMed ID: 26563499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autophagy and misfolded proteins in neurodegeneration.
    Metcalf DJ; García-Arencibia M; Hochfeld WE; Rubinsztein DC
    Exp Neurol; 2012 Nov; 238(1):22-8. PubMed ID: 21095248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Influence of Cyclo(His-Pro) on Proteostasis: Impact on Neurodegenerative Diseases.
    Grottelli S; Costanzi E; Peirce MJ; Minelli A; Cellini B; Bellezza I
    Curr Protein Pept Sci; 2018; 19(8):805-812. PubMed ID: 29708066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular chaperone dysfunction in neurodegenerative diseases and effects of curcumin.
    Maiti P; Manna J; Veleri S; Frautschy S
    Biomed Res Int; 2014; 2014():495091. PubMed ID: 25386560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
    Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
    Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotection Through Rapamycin-Induced Activation of Autophagy and PI3K/Akt1/mTOR/CREB Signaling Against Amyloid-β-Induced Oxidative Stress, Synaptic/Neurotransmission Dysfunction, and Neurodegeneration in Adult Rats.
    Singh AK; Kashyap MP; Tripathi VK; Singh S; Garg G; Rizvi SI
    Mol Neurobiol; 2017 Oct; 54(8):5815-5828. PubMed ID: 27660271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of autophagy by mTOR-dependent and mTOR-independent pathways: autophagy dysfunction in neurodegenerative diseases and therapeutic application of autophagy enhancers.
    Sarkar S
    Biochem Soc Trans; 2013 Oct; 41(5):1103-30. PubMed ID: 24059496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autophagy in neurodegenerative diseases: From pathogenic dysfunction to therapeutic modulation.
    Martinez-Vicente M
    Semin Cell Dev Biol; 2015 Apr; 40():115-26. PubMed ID: 25843774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting autophagy in neurodegenerative diseases.
    Vidal RL; Matus S; Bargsted L; Hetz C
    Trends Pharmacol Sci; 2014 Nov; 35(11):583-91. PubMed ID: 25270767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological Tools to Modulate Autophagy in Neurodegenerative Diseases.
    Suresh SN; Chakravorty A; Giridharan M; Garimella L; Manjithaya R
    J Mol Biol; 2020 Apr; 432(8):2822-2842. PubMed ID: 32105729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clearance of misfolded and aggregated proteins by aggrephagy and implications for aggregation diseases.
    Hyttinen JM; Amadio M; Viiri J; Pascale A; Salminen A; Kaarniranta K
    Ageing Res Rev; 2014 Nov; 18():16-28. PubMed ID: 25062811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in autophagy-based neuroprotection.
    Radad K; Moldzio R; Al-Shraim M; Kranner B; Krewenka C; Rausch WD
    Expert Rev Neurother; 2015 Feb; 15(2):195-205. PubMed ID: 25614954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced Clearance of Neurotoxic Misfolded Proteins by the Natural Compound Berberine and Its Derivatives.
    Rusmini P; Cristofani R; Tedesco B; Ferrari V; Messi E; Piccolella M; Casarotto E; Chierichetti M; Cicardi ME; Galbiati M; Geroni C; Lombardi P; Crippa V; Poletti A
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32414108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagy and the Metabolism of Misfolding Protein.
    Cheng C; Liu ZG
    Adv Exp Med Biol; 2019; 1206():375-420. PubMed ID: 31776995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.